Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 48, 2018 - Issue 12
307
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Bis coumarinyl bis triazolothiadiazinyl ethane derivatives: Synthesis, antiviral activity evaluation, and molecular docking studies

, , , , &
Pages 1494-1503 | Received 17 Dec 2017, Published online: 23 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sobhi M. Gomha, Sayed M. Riyadh, Thoraya A. Farghaly & Reda A. Haggam. (2023) Synthetic Utility of Bis-Aminomercapto[1,2,4] Triazoles in the Preparation of Bis- Fused Triazoles and Macrocycles. Polycyclic Aromatic Compounds 43:4, pages 3720-3740.
Read now

Articles from other publishers (12)

Dilipkumar Pal, Kamal Bareth, Priyanka Rani, Chandi Charan Kandar & Abhishek Mishra. 2024. Anti-Viral Metabolites from Medicinal Plants. Anti-Viral Metabolites from Medicinal Plants 1039 1065 .
Mohammed Alwan Farhan, Wijdan Amer Ibrahim & Wassan Baqir Ali. (2023) Synthesis, Evaluation of anticancer and antimicrobial activities of some Schiff bases derivatives. Al-Kitab Journal for Pure Sciences 7:2, pages 115-129.
Crossref
Andrey V. Khramchikhin, Mariya A. Skryl’nikova, Iana L. Esaulkova, Ekaterina O. Sinegubova, Vladimir V. Zarubaev, Maxim A. Gureev, Aleksandra M. Puzyk & Vladimir A. Ostrovskii. (2022) Novel [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine and [1,2,4]triazolo[3,4-b][1,3,4]thiadiazepine Derivatives: Synthesis, Anti-Viral In Vitro Study and Target Validation Activity. Molecules 27:22, pages 7940.
Crossref
Ranjana Aggarwal, Mona Hooda, Prince Kumar & Garima Sumran. (2022) Vision on Synthetic and Medicinal Facets of 1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine Scaffold. Topics in Current Chemistry 380:2.
Crossref
Moaz M. Abdou, Ahmed Abu-Rayyan, Ahmed G. Bedir, S. Abdel-Fattah, A. M. A. Omar, Abdullah A. Ahmed, El-Sayed I. El-Desoky & Eslam A. Ghaith. (2021) 3-(Bromoacetyl)coumarins: unraveling their synthesis, chemistry, and applications. RSC Advances 11:61, pages 38391-38433.
Crossref
Nabeel A. Abdul-Ridha, Afraah D. Salmaan, Rita Sabah, Bahjat Saeed & Najim A. Al-Masoudi. (2021) Synthesis, cytotoxicity and in silico study of some novel benzocoumarin-chalcone-bearing aryl ester derivatives and benzocoumarin-derived arylamide analogs . Zeitschrift für Naturforschung B 76:3-4, pages 201-210.
Crossref
Yanni Lai, Tiantian Han, Shaofeng Zhan, Yong Jiang, Xiaohong Liu & Geng Li. (2021) Antiviral Activity of Isoimperatorin Against Influenza A Virus in vitro and its Inhibition of Neuraminidase. Frontiers in Pharmacology 12.
Crossref
Osvaldo Yañez, Manuel Isaías Osorio, Eugenio Uriarte, Carlos Areche, William Tiznado, José M. Pérez-Donoso, Olimpo García-Beltrán & Fernando González-Nilo. (2021) In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease. Frontiers in Chemistry 8.
Crossref
S. A. El‐Sebaey. (2020) Recent Advances in 1,2,4‐Triazole Scaffolds as Antiviral Agents. ChemistrySelect 5:37, pages 11654-11680.
Crossref
Sayed M. Riyadh & Sobhi M. Gomha. (2020) Two decades of the synthesis of mono- and bis-aminomercapto[1,2,4]triazoles. RSC Advances 10:42, pages 24994-25012.
Crossref
Francesca Annunziata, Cecilia Pinna, Sabrina Dallavalle, Lucia Tamborini & Andrea Pinto. (2020) An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities. International Journal of Molecular Sciences 21:13, pages 4618.
Crossref
Shruti Mishra, Achyut Pandey & Siddharth Manvati. (2020) Coumarin: An emerging antiviral agent. Heliyon 6:1, pages e03217.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.